<qa>  What is the purpose of the study?The aim of this study is to determine if the Investigational Medicinal Product Tedopi OSE2101 is more effective than standard treatment in treating patients with stage IIIB NSCLC unsuitable for radiotherapy or metastatic NSCLC in second- or third-line treatment. 